Anixa Biosciences, Inc. is an innovative biotechnology company headquartered in San Jose, California, dedicated to addressing critical unmet needs in oncology and infectious disease through the development of advanced therapies and vaccines. The company's robust pipeline leverages cutting-edge technologies to create novel solutions aimed at improving patient outcomes in challenging medical conditions. With a strategic focus on high-impact areas, Anixa is well-positioned to contribute significantly to the evolving landscape of biopharmaceuticals.